We’ve been having a look back at what a great year 2014 was for Oncology Central this week and reviewing which of the year’s content you found most engaging.
Below you can find a full round up of the 10 top read articles and news stories of the year – a diverse list covering many areas of the broad field of oncology. Have you read them yet? Catch up on 2014 on the OC now and feel free to leave us your comments.
Top read articles of 2014:
•Engulfing losers by winners in cancer: do cancer stem cells catch eat-me signals from noncancer stem cells?
•Grading neuroendocrine tumors: are we there?
•How can we manage resistance to antiangiogenic drugs?
•Considerations on the prognostic and predictive significance of HLA-G in breast cancer
•Positive sentinel lymph node: the evolution of axillary surgery and intraoperative assessment of sentinel lymph nodes
•γδ T cells as a potential tool in colon cancer immunotherapy
•Current management of colorectal liver metastases
•Tamoxifen as the first successful targeted therapy in cancer: the gift that kept on giving
•Clinical significance of FGFR1 gene amplification in lung cancer patients
•Waldenström macroglobulinemia at 70
Top read headlines of 2014:
•Glioblastoma animal studies result in trial of potential new combination therapy
•Ultraviolet light-induced mutation drives many skin cancers, researchers find
•Study shows screening for prostate cancer could reduce prostate cancer deaths by one fifth
•Breast cancer recurrence rate may be reduced in obese women who take NSAIDs
•Phase III rolapitant trial demonstrates significant reductions in nausea and vomiting
•Cirmtuzumab enters Phase I trial for the treatment of chronic lymphocytic leukemia
•Novel breast cancer biomarker crosses subtype boundaries
•Novel gene could predict metastatic potential of breast tumors
•Osteoporosis treatment reduces risk of breast cancer bone metastases in first study of its kind
•‘Breakthrough Therapy’ shows promise in acute lymphoblastic leukemia